Sotorasib long-term clinical outcomes in pretreated KRAS G12C-mutated advanced NSCLC: Pooled analysis from the CodeBreaK clinical trials Meeting Abstract
| Authors: | Skoulidis, F.; Li, B. T.; Hochmair, M. J.; Govindan, R.; Vincent, M.; Van Der Wekken, A. J.; Reguart Aransay, N.; O'Byrne, K. J.; Girard, N.; Griesinger, F.; Nishio, M.; Häfliger, S.; Lindsay, C.; Reinmuth, N.; Paulus, A.; Papakotoulas, P.; Obiozor, C.; Nduka, C.; Wang, Y.; De Langen, A. J. |
| Abstract Title: | Sotorasib long-term clinical outcomes in pretreated KRAS G12C-mutated advanced NSCLC: Pooled analysis from the CodeBreaK clinical trials |
| Meeting Title: | ESMO Congress 2024 |
| Journal Title: | Annals of Oncology |
| Volume: | 35 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2024 Sep 13-17 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-09-01 |
| Start Page: | S830 |
| End Page: | S831 |
| Language: | English |
| ACCESSION: | WOS:001326612901607 |
| DOI: | 10.1016/j.annonc.2024.08.1362 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1305P -- Source: Wos |
